Terren S. Peizer - May 11, 2021 Form 4/A - restatement Insider Report for Ontrak, Inc. (OTRK)

Role
Executive Chairman, Director, 10%+ Owner
Signature
Acuitas Group Holdings , LLC, Terren S. Peizer , Chairman /s/ Terren S. Peizer
Stock symbol
OTRK
Transactions as of
May 11, 2021
Transactions value $
$1,374,706
Form type
4/A - RESTATEMENT
Date filed
5/14/2021, 09:46 PM
Date Of Original Report
May 11, 2021
Previous filing
May 11, 2021
Next filing
May 18, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction OTRK Common Stock Exercise of in-the-money or at-the-money derivative security $2.39 M +499 K +5.42% $4.80 9.71 M May 10, 2021 By Acuitas F1, F2, F3
transaction OTRK Common Stock Sale -$31.6 K -1.1 K -0.01% $28.71 9.71 M May 11, 2021 By Acuitas F1, F4, F5
transaction OTRK Common Stock Sale -$100 K -3.4 K -0.04% $29.47 9.71 M May 11, 2021 By Acuitas F1, F4, F6
transaction OTRK Common Stock Sale -$63.9 K -2.09 K -0.02% $30.58 9.7 M May 11, 2021 By Acuitas F1, F4, F7
transaction OTRK Common Stock Sale -$85.4 K -2.7 K -0.03% $31.63 9.7 M May 11, 2021 By Acuitas F1, F4, F8
transaction OTRK Common Stock Sale -$55.1 K -1.71 K -0.02% $32.22 9.7 M May 11, 2021 By Acuitas F1, F4, F9
transaction OTRK Common Stock Sale -$203 K -6.5 K -0.07% $31.27 9.69 M May 12, 2021 By Acuitas F1, F4, F10
transaction OTRK Common Stock Sale -$144 K -4.5 K -0.05% $31.96 9.69 M May 12, 2021 By Acuitas F1, F4, F11
transaction OTRK Common Stock Sale -$198 K -6.63 K -0.07% $29.92 9.68 M May 13, 2021 By Acuitas F1, F4, F12
transaction OTRK Common Stock Sale -$39.5 K -1.27 K -0.01% $31.07 9.68 M May 13, 2021 By Acuitas F1, F4, F13
transaction OTRK Common Stock Sale -$99 K -3.1 K -0.03% $31.93 9.68 M May 13, 2021 By Acuitas F1, F4, F14

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OTRK Warrants to Purchase Exercise of in-the-money or at-the-money derivative security $0 -499 K -100% $0.00 0 May 10, 2021 Common Stock 499 K $4.80 By Acuitas F1, F2

Explanation of Responses:

Id Content
F1 This Form 4 is jointly filed by Terren S. Peizer ("Mr. Peizer") and Acuitas Group Holdings, LLC ("Acuitas"). Mr. Peizer is the Chairman and sole member of Acuitas and, in such capacity, exercises voting and investment power over any securities held for the accounts of Acuitas.
F2 On May 11, 2021, the Reporting Persons filed a Form 4 (the "May 11 Form 4") which incorrectly reported, due to a clerical error, that on May 10, 2021, Acuitas exercised, on a cashless basis, a warrant to purchase 498,297 shares of the issuer's common stock for $4.80 per share. In fact, as reported in this Form 4, on May 10, 2021, Acuitas exercised, on a cashless basis, a warrant to purchase 498,927 shares of the issuer's common stock (rather than 498,297 shares) for $4.80 per share.
F3 This Form 4 also corrects the total number of shares of the issuer's common stock beneficially owned by the Reporting Persons following the exercise of all warrants reported on the May 11 Form 4 (net of the issuer's withholding of an aggregate of 89,572 shares in respect of the exercise prices for such warrants), which was incorrectly reported on the May 11 Form 4 as 9,709,882 shares. In fact, as reported in this Form 4, following the exercise of all such warrants on May 10, 2021 (and after giving effect to the issuer's withholding of shares in respect of the exercise prices for such warrants), the Reporting Persons beneficially owned an aggregate of 9,710,512 shares of the issuer's common stock.
F4 Represents sales effected pursuant to a Rule 10b5-1 trading plan entered into by Acuitas on May 10, 2021. The shares sold pursuant to such sales were acquired by Acuitas pursuant to the exercise of warrants held by Acuitas on May 10, 2021, which warrants were set to expire on August 15, 2021 and August 30, 2021.
F5 The price reported is a volume weighted average price. The shares were sold in multiple transactions at prices ranging from $28.090 to $29.070, inclusive. The Reporting Persons undertake to provide the issuer, any security holder of the issuer, and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The price reported is a volume weighted average price. The shares were sold in multiple transactions at prices ranging from $29.120 to $30.050, inclusive. The Reporting Persons undertake to provide the issuer, any security holder of the issuer, and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 The price reported is a volume weighted average price. The shares were sold in multiple transactions at prices ranging from $30.130 to $31.000, inclusive. The Reporting Persons undertake to provide the issuer, any security holder of the issuer, and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8 The price reported is a volume weighted average price. The shares were sold in multiple transactions at prices ranging from $31.220 to $32.080, inclusive. The Reporting Persons undertake to provide the issuer, any security holder of the issuer, and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9 The price reported is a volume weighted average price. The shares were sold in multiple transactions at prices ranging from $32.120 to $32.290, inclusive. The Reporting Persons undertake to provide the issuer, any security holder of the issuer, and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F10 The price reported is a volume weighted average price. The shares were sold in multiple transactions at prices ranging from $30.710 to $31.660, inclusive. The Reporting Persons undertake to provide the issuer, any security holder of the issuer, and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F11 The price reported is a volume weighted average price. The shares were sold in multiple transactions at prices ranging from $31.710 to $32.490, inclusive. The Reporting Persons undertake to provide the issuer, any security holder of the issuer, and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F12 The price reported is a volume weighted average price. The shares were sold in multiple transactions at prices ranging from $29.510 to $30.500, inclusive. The Reporting Persons undertake to provide the issuer, any security holder of the issuer, and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F13 The price reported is a volume weighted average price. The shares were sold in multiple transactions at prices ranging from $30.690 to $31.460, inclusive. The Reporting Persons undertake to provide the issuer, any security holder of the issuer, and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F14 The price reported is a volume weighted average price. The shares were sold in multiple transactions at prices ranging from $31.530 to $32.335, inclusive. The Reporting Persons undertake to provide the issuer, any security holder of the issuer, and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

The original Form 4 filed by the Reporting Persons on May 13, 2021 inadvertently omitted a footnote, which is included as footnote 4 in this Form 4/A. The omission of such footnote caused subsequent footnotes in the original Form 4 to be numbered incorrectly. This Form 4/A is being filed solely to correct these clerical errors, and no other changes are being made to the original Form 4.